Gastric cancer treatment can be especially challenging because patients often struggle with eating, maintaining weight, and ...

Akeso, Inc. (9926.HK) (Akeso or the Company) announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric cancer evaluating cadonilimab, a first-in ...

Arcus Biosciences said it will discontinue a late-stage trial for its potential cancer treatment due to futility. The study, which was being conducted in partnership with Gilead Sciences, aimed to ...

Danielle Fishel shared that following the completion of her breast cancer treatment, she's feeling healthy and positive ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the ...

SIR Cliff Richard has backed calls for a prostate cancer national screening test for men, and wants King Charles to raise ...

Arcus Biosciences and Gilead Sciences are discontinuing a Phase 3 trial of an experimental cancer treatment after an interim review showed the therapy was unlikely to help patients live longer.

Equity-Insider.com News Commentary – The FDA approved the first perioperative immunotherapy for early gastric and gastroesophageal junction cancers last month, ushering ...

The latest announcement is out from Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ). Shanghai Henlius Biotech, Inc. announced that its New ...

Arcus Biosciences said on Friday it would stop a late-stage study testing its experimental cancer drug combination in ...

UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and ...